Algert Global LLC Makes New $2.88 Million Investment in Plexus Corp. $PLXS

Algert Global LLC purchased a new stake in Plexus Corp. (NASDAQ:PLXS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 9,590 shares of the technology company's stock, valued at approximately $2,883,000.

Other institutional investors have also added to or reduced their stakes in the company. OMERS ADMINISTRATION Corp bought a new position in Plexus during the 2nd quarter valued at about $7,950,000. Sanctuary Advisors LLC purchased a new position in Plexus in the second quarter valued at $432,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Plexus during the 2nd quarter worth $35,755,000. Northwestern Mutual Wealth Management Co. acquired a new stake in Plexus in the second quarter valued at approximately $584,000. Finally, Evolve Private Wealth LLC acquired a new position in shares of Plexus in the second quarter valued at approximately $1,102,000. Hedge funds and other institutional investors own 94.45% of the company's stock.

Plexus Stock Performance

Shares of Plexus stock opened at $240.87 on Friday. Plexus Corp. has a 12 month low of $132.03 and a 12 month high of $307.06. The stock's fifty day moving average price is $263.63 and its 200-day moving average price is $243.97. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06. The firm has a market cap of $6.45 billion, a P/E ratio of 35.53 and a beta of 0.90.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts' consensus estimates of $2.13 by $0.19. The firm had revenue of $1.30 billion for the quarter, compared to analyst estimates of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The business's quarterly revenue was up 28.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.64 earnings per share. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. On average, equities research analysts expect that Plexus Corp. will post 7.11 earnings per share for the current fiscal year.

Insider Buying and Selling at Plexus

In other news, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $294.98, for a total transaction of $442,470.00. Following the sale, the chief executive officer directly owned 68,888 shares of the company's stock, valued at approximately $20,320,582.24. The trade was a 2.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael V. Schrock sold 4,000 shares of Plexus stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the sale, the director owned 40,329 shares in the company, valued at approximately $11,090,475. This represents a 9.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 8,510 shares of company stock valued at $2,347,747 over the last ninety days. Corporate insiders own 1.78% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PLXS. Stifel Nicolaus upped their price objective on shares of Plexus from $280.00 to $330.00 and gave the company a "buy" rating in a research report on Monday, June 22nd. Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and set a $308.00 price objective for the company in a research report on Friday, July 31st. Zacks Research upgraded Plexus from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 11th. Wall Street Zen upgraded shares of Plexus from a "hold" rating to a "buy" rating in a report on Saturday, May 2nd. Finally, Needham & Company LLC restated a "buy" rating and set a $310.00 price target on shares of Plexus in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the company. According to MarketBeat.com, Plexus currently has an average rating of "Buy" and an average price target of $273.00.

Plexus Profile

Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source